These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 14990978)
1. Predictive factors for successful stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine. Morgan SJ; Seymour JF; Grigg A; Matthews JP; Prince HM; Wolf MM; Januszewicz EH Leukemia; 2004 May; 18(5):1034-8. PubMed ID: 14990978 [No Abstract] [Full Text] [Related]
2. Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator. Herbert KE; Morgan S; Prince HM; Westerman DA; Wolf MM; Carney DA; Yuen K; di Iulio J; Seymour JF Leukemia; 2009 Feb; 23(2):305-12. PubMed ID: 18987661 [TBL] [Abstract][Full Text] [Related]
3. Mobilization of peripheral blood stem cells in CLL patients after front-line fludarabine treatment. Lysak D; Koza V; Steinerova K; Jindra P; Vozobulova V; Schutzova M Ann Hematol; 2005 Jul; 84(7):456-61. PubMed ID: 15770494 [TBL] [Abstract][Full Text] [Related]
5. Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. Jantunen E; Itälä M; Siitonen T; Kuittinen T; Heiskanen J; Koivunen E; Juvonen E; Silvennoinen R; Nousiainen T; Koistinen P; Volin L; Remes K Bone Marrow Transplant; 2008 Feb; 41(3):239-44. PubMed ID: 17968327 [TBL] [Abstract][Full Text] [Related]
6. Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders. Altés A; López R; Martino R; Martinez C; Cabezudo E; Muñoz L; Santamaría A; Perea G; Briones J; Salar A; Sureda A; Brunet S; Madoz P; Sierra J Bone Marrow Transplant; 2000 Jul; 26(2):127-32. PubMed ID: 10918421 [TBL] [Abstract][Full Text] [Related]
7. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation. Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420 [TBL] [Abstract][Full Text] [Related]
8. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders]. Pawelski S Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771 [TBL] [Abstract][Full Text] [Related]
9. Successful peripheral blood stem cell harvesting with granulocyte colony-stimulating factor alone after previous mobilization failure. Lefrère F; Lévy V; Makke J; Audat F; Cavazzana-Calvo M; Micléa JM Haematologica; 2004 Dec; 89(12):1532-4. PubMed ID: 15590409 [TBL] [Abstract][Full Text] [Related]
10. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor. Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594 [TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493 [TBL] [Abstract][Full Text] [Related]
13. Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma. Ozsan GH; Micallef IN; Dispenzieri A; Kumar S; Lacy MQ; Dingli D; Hayman SR; Buadi FK; Wolf RC; Gastineau DA; Hogan WJ; Gertz MA Am J Hematol; 2012 Jan; 87(1):1-4. PubMed ID: 21959988 [TBL] [Abstract][Full Text] [Related]
14. Autologous transplantation with peripheral blood stem cells in chronic lymphocytic leukemia. A phase III, randomized, multicenter study. GIMEMA. Gruppo Italiano per le Malattie Ematologiche dell'Adulto. GITMO-Gruppo Italiano Trapianto di Midollo Osseo. Hematol Cell Ther; 1999 Jun; 41(3):117-25. PubMed ID: 10456442 [No Abstract] [Full Text] [Related]
15. Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation. Waterman J; Rybicki L; Bolwell B; Copelan E; Pohlman B; Sweetenham J; Dean R; Sobecks R; Andresen S; Kalaycio M Bone Marrow Transplant; 2012 Apr; 47(4):488-93. PubMed ID: 21572461 [TBL] [Abstract][Full Text] [Related]
16. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function. Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017 [TBL] [Abstract][Full Text] [Related]
17. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study. de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253 [TBL] [Abstract][Full Text] [Related]
18. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation]. Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529 [TBL] [Abstract][Full Text] [Related]